Weight Management in Menopausal Women: The Role of GLP-1 Therapy, nternational Journal of Obesity
Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus
WorldatWork & IFEBP, 2024) The Data Explained: GLP-1 Coverage Adoption Coverage for GLP-1s among large employers (500+ employees) grew from 41% in 2023 to 44% in 2024, with projections showing continued expansion as employers weigh cost versus employee demand (Intercept Health, HR Dive)
Characterized by insulin resistance, gradual progressive loss of insulin secretion by -cells, and being heavily driven by being overweight or obese [98], T2DM leads to hyperglycemia, excessive urine production, increased risk of cardiovascular disease, and changes in energy metabolism [106]
Ready to explore whether peptides fit into your wellness plan
Confirm the current program terms and your eligibility on the manufacturer's website at the time you fill your prescription